Oruka Therapeutics Inc. (ORKA) Live Share Price, Invest From India

Oruka Therapeutics Inc. Stock Performance

as on June 23, 2026 at 1:19 am IST

Day's Low
Day's High
$81.34
Day's Price Range
$84.59
$82.11
0.94%
Downside
3.02%
Upside
52 Week's Low
52 Week's High
$10.77
52-Week Price Range
$91.00
$82.11
86.88%
Downside
10.83%
Upside

Oruka Therapeutics Inc. share price movements today

Previous Close: $72.34
Open: $82.93
Volume: 567.8K
Day's Low - High: $81.34 - $84.59
52 Week Low - High: $10.77 - $91.00

Oruka Therapeutics Inc. Historical Returns

1 Month Return: + 19.35 %
3 Month Return: + 85.92 %
1 Year Return: + 519.35 %
3 Year Return: 0 %
5 Year Return: 0 %

Oruka Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Oruka Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.4B

EPS (TTM)

-2.0369

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-27.31%

Oruka Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oruka Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Oruka Therapeutics Inc.	NA	$4.4B	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.1B	60.79%	69.87	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$114.6B	139.12%	26.8	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.9B	14.22%	14.88	29.65%	0.59%

Stock Returns calculator for Oruka Therapeutics Inc. Stock including INR - Dollar returns

The Oruka Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Oruka Therapeutics Inc. investment value today

Current value as on today

₹7,68,765

Returns

₹6,68,765

(+668.77%)

Returns from Oruka Therapeutics Inc. Stock

₹6,02,997 (+603%)

Dollar Impact

₹65,769 (+65.77%)

Indian Investors' Interest in Oruka Therapeutics Inc. Stock

Search interest for Oruka Therapeutics Inc. Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 23, 2026 to June 22, 2026

Change:-67% versus previous 30 day period

Oruka Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-	0	0
Operating Income	-2	-21	-29	-25	-28	-34	-34	-36
EBITDA	-1	-22	-28	-20	-24	-30	-29	-31
Interest Expense	0	0	0	-	-	-	-	-
Depreciation	-	-	-	0	0	0	0	0
Income Before Tax	-2	-22	-28	-20	-24	-30	-29	-31
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-2	-22	-28	-20	-24	-30	-29	-31
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Oruka Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	0
Operating Income	-122
EBITDA	-105
Interest Expense	-
Depreciation	0
Income Before Tax	-105
Income Tax Expense	-
Net Income	-105
Net Profit Margin	0.00%

Oruka Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-2	-28	-25	-20	-24	-30	-29	-31
Operating Cash Flow	0	-2	-34	-18	-20	-23	-21	-22	-23
Investing Cash Flow	-	-	0	-329	42	4	-122	-22	-14
Financing Cash Flow	27	0	450	0	-	0	169	0	40
Change in Cash	27	-2	377	-349	21	-18	25	-44	2

Oruka Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2024	Dec 2025
Net Income	-16	-18	-7	-5	-9	-19	-9	-83	-105
Operating Cash Flow	-14	-17	-8	-4	-7	-18	-10	-57	-88
Investing Cash Flow	-16	12	3	0	0	0	0	-330	-96
Financing Cash Flow	-	5	3	6	48	23	-	449	170
Change in Cash	-31	1	-2	1	40	4	-10	24	-14

Global Institutional Holdings in Oruka Therapeutics Inc.

Funds	Holdings
Paradigm Biocapital Advisors LP	3.85%
Point72 Asset Management, L.P.	0.99%
Remedium Capital Partners, LLC	2.57%
Polar Capital Holdings PLC	1.74%
FMR Inc	12.32%

See all

Insights on Oruka Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, ORKA stock has moved up by 19.4%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ORKA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ORKA has outperformed top 5 stocks with highest market-cap in its industry

About Oruka Therapeutics Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Organisation	Oruka Therapeutics Inc.
Headquarters	855 Oak Grove Avenue, Menlo Park, CA, United States, 94025
Industry	Biotechnology
CEO	Dr. Lawrence Otto Klein Ph.D.
E-voting on shares	Click here to vote

Key Management of Oruka Therapeutics Inc.

Name	Title
Mr. Arjun Agarwal CPA	Senior VP of Finance & Treasurer
Ms. Laura Sandler	Chief Operating Officer
Mr. Alan Lada	VP of IR & Capital Markets
Mr. Christopher Finch	Senior VP and Head of Business Development & Strategy
Dr. Rajiv Panwar	Senior VP and Head of Chemistry, Manufacturing & Controls
Dr. Lawrence Otto Klein Ph.D.	President, CEO & Director
Mr. Paul T. Quinlan	General Counsel & Secretary
Dr. Joana Goncalves M.D.	Chief Medical Officer

FAQs

What is Oruka Therapeutics Inc. share price today?

Oruka Therapeutics Inc. share price today is $82.11 as on June 22, 2026 at 7:49 pm IST. Oruka Therapeutics Inc. share today touched a day high of $84.59 and a low of $81.34.

What is the 52 week high and 52 week low for Oruka Therapeutics Inc. share?

Oruka Therapeutics Inc. share touched a 52 week high of $91 on April 27, 2026 and a 52 week low of $10.77 on June 23, 2025. Oruka Therapeutics Inc. stock price today i.e. June 22, 2026 at 7:49 pm IST is trending at $82.11,which is 9.77% down from its 52 week high and 662.40% up from its 52 week low.

What is Oruka Therapeutics Inc.'s market capitalisation today?

Oruka Therapeutics Inc. market capitalisation is $0.00T as on June 22, 2026 at 7:49 pm IST.

How to invest in Oruka Therapeutics Inc. Stock (ORKA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oruka Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oruka Therapeutics Inc. Shares that will get you 0.0183 shares as per Oruka Therapeutics Inc. share price of $82.11 per share as on June 22, 2026 at 7:49 pm IST.

What is the minimum amount required to buy Oruka Therapeutics Inc. Stock (ORKA) from India?

Indian investors can start investing in Oruka Therapeutics Inc. (ORKA) shares with as little as ₹94.68 or $1 (as of June 22, 2026 at 7:49 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in Oruka Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 22, 2026 at 7:49 pm IST). Based on Oruka Therapeutics Inc. share’s latest price of $82.11 as on June 22, 2026 at 7:49 pm IST, you will get 0.1218 shares of Oruka Therapeutics Inc.. Learn more about fractional shares .